BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 9485010)

  • 1. Telomerase activity in prostate cancer, prostatic intraepithelial neoplasia, and benign prostatic epithelium.
    Zhang W; Kapusta LR; Slingerland JM; Klotz LH
    Cancer Res; 1998 Feb; 58(4):619-21. PubMed ID: 9485010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the RNA component of human telomerase (hTR) in prostate cancer, prostatic intraepithelial neoplasia, and normal prostate tissue.
    Paradis V; Dargère D; Laurendeau I; Benoît G; Vidaud M; Jardin A; Bedossa P
    J Pathol; 1999 Oct; 189(2):213-8. PubMed ID: 10547577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of telomerase activity in prostate needle-biopsy samples].
    Wang X; Zhang Y; Ding Q; Ye L; Zhai L; Jia W
    Zhonghua Wai Ke Za Zhi; 1999 Dec; 37(12):762-4. PubMed ID: 11829949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase activity, telomere length, and DNA ploidy in prostatic intraepithelial neoplasia (PIN).
    Koeneman KS; Pan CX; Jin JK; Pyle JM; Flanigan RC; Shankey TV; Diaz MO
    J Urol; 1998 Oct; 160(4):1533-9. PubMed ID: 9751408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase activity: a prevalent marker of malignant human prostate tissue.
    Sommerfeld HJ; Meeker AK; Piatyszek MA; Bova GS; Shay JW; Coffey DS
    Cancer Res; 1996 Jan; 56(1):218-22. PubMed ID: 8548767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase activity in primary prostate cancer.
    Lin Y; Uemura H; Fujinami K; Hosaka M; Harada M; Kubota Y
    J Urol; 1997 Mar; 157(3):1161-5. PubMed ID: 9072562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of high grade prostatic intraepithelial neoplasia on serum total and percentage of free prostate specific antigen levels.
    Ramos CG; Carvahal GF; Mager DE; Haberer B; Catalona WJ
    J Urol; 1999 Nov; 162(5):1587-90. PubMed ID: 10524873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase as a tumor marker in diagnosis of prostatic intraepithelial neoplasia and prostate cancer.
    Glybochko PV; Zezerov EG; Glukhov AI; Alyaev YG; Severin SE; Polyakovsky KA; Varshavsky VA; Severin ES; Vinarov AZ
    Prostate; 2014 Jul; 74(10):1043-51. PubMed ID: 24854433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase reverse transcriptase subunit immunoreactivity: a marker for high-grade prostate carcinoma.
    Iczkowski KA; Pantazis CG; McGregor DH; Wu Y; Tawfik OW
    Cancer; 2002 Dec; 95(12):2487-93. PubMed ID: 12467061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone.
    Leav I; McNeal JE; Ho SM; Jiang Z
    Hum Pathol; 2003 Mar; 34(3):228-33. PubMed ID: 12673556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer.
    Bostwick DG; Alexander EE; Singh R; Shan A; Qian J; Santella RM; Oberley LW; Yan T; Zhong W; Jiang X; Oberley TD
    Cancer; 2000 Jul; 89(1):123-34. PubMed ID: 10897009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive detection of prostate cancer by quantitative analysis of telomerase activity.
    Botchkina GI; Kim RH; Botchkina IL; Kirshenbaum A; Frischer Z; Adler HL
    Clin Cancer Res; 2005 May; 11(9):3243-9. PubMed ID: 15867219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human telomerase and alpha-methylacyl-coenzyme A racemase in prostatic carcinoma. A comparative immunohistochemical study.
    Puebla-Mora AG; Heras A; Cano-Valdez AM; Domínguez-Malagón H
    Ann Diagn Pathol; 2006 Aug; 10(4):205-8. PubMed ID: 16844561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced 15-lipoxygenase-2 immunostaining in prostate adenocarcinoma: correlation with grade and expression in high-grade prostatic intraepithelial neoplasia.
    Jack GS; Brash AR; Olson SJ; Manning S; Coffey CS; Smith JA; Shappell SB
    Hum Pathol; 2000 Sep; 31(9):1146-54. PubMed ID: 11014584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
    Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Bostwick DG
    J Urol; 1999 Apr; 161(4):1229-32. PubMed ID: 10081875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-grade prostatic intraepithelial neoplasia with adjacent small atypical glands on prostate biopsy.
    Kronz JD; Shaikh AA; Epstein JI
    Hum Pathol; 2001 Apr; 32(4):389-95. PubMed ID: 11331955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancer.
    Sinha AA; Quast BJ; Reddy PK; Lall V; Wilson MJ; Qian J; Bostwick DG
    Exp Mol Pathol; 2004 Oct; 77(2):153-9. PubMed ID: 15351240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human telomerase reverse transcriptase expression correlates with vascular endothelial growth factor-promoted tumor cell proliferation in prostate cancer.
    Tang J; Wang Z; Li X; Li J; Shi H
    Artif Cells Blood Substit Immobil Biotechnol; 2008; 36(2):83-93. PubMed ID: 18437586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of thrombospondin-1 in benign prostatic hyperplasia and prostatic intraepithelial neoplasia is decreased in prostate cancer.
    Vallbo C; Wang W; Damber JE
    BJU Int; 2004 Jun; 93(9):1339-43. PubMed ID: 15180634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: change in cellular localization associated with high-grade prostatic intraepithelial neoplasia.
    Upadhyay J; Shekarriz B; Nemeth JA; Dong Z; Cummings GD; Fridman R; Sakr W; Grignon DJ; Cher ML
    Clin Cancer Res; 1999 Dec; 5(12):4105-10. PubMed ID: 10632347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.